Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  

Merck Patient Assistance Program

This program provides brand name medications at no or low cost

Provided by: Merck Patient Assistance, Inc.

PO Box 690
Horsham, PA 19044-9979

TEL: 800-727-5400

Languages Spoken:

English, Spanish

Program Website


Patient Assistance Applications

Merck Patient Assistance Program Enrollment Form

Merck Patient Assistance Program Enrollment Form (Spanish)

Merck Patient Assistance Program Enrollment Form Instruction Letter (Spanish)


Brand Name Medications Covered

  • Asmanex HFA aerosol; inhalation
  • Lotrisone
  • Asmanex Twisthaler powder; inhalation
  • Maxalt tablet
  • Belsomra tablet
  • Maxalt-MLT tablet; orally disintegrating
  • Crixivan
  • Nasonex spray; nasal
  • Dificid
  • Nitro-Dur transdermal
  • Dulera aerosol; inhalation
  • Proventil HFA aerosol; inhalation
  • Elocon
  • Singulair granule; oral
  • Emend
  • Sivextro
  • Emend injection
  • Stromectol tablet
  • Emend suspension
  • Sylatron
  • Intron A
  • Temodar capsule
  • Isentress
  • Trusopt ophthalmic solution/drops
  • Isentress HD tablet
  • Vytorin tablet
  • Janumet tablet
  • Zetia tablet
  • Janumet XR tablet; extended release
  • Zolinza
  • Januvia tablet

Generic Name

  • albuterol sulfate aerosol; inhalation
  • mometasone furoate aerosol; inhalation
  • aprepitant
  • mometasone furoate monohydrate spray; nasal
  • aprepitant suspension
  • mometasone furoate powder; inhalation
  • clotrimazole/betamethasone
  • montelukast sodium granule; oral
  • dorzolamide ophthalmic solution/drops
  • nitroglycerin transdermal
  • ezetimibe tablet
  • peginterferon alfa-2b
  • ezetimibe/simvastatin tablet
  • raltegravir
  • fidaxomicin
  • raltegravir tablet
  • formoterol fumarate/mometasone furoate aerosol; inhalation
  • rizatriptan benzoate tablet
  • fosaprepitant dimeglumine injection
  • rizatriptan benzoate tablet; orally disintegrating
  • indinavir sulfate
  • sitagliptin tablet
  • interferon alfa-2b
  • suvorexant tablet
  • ivermectin tablet
  • tedizolid
  • metformin/sitagliptin tablet
  • temozolomide capsule
  • metformin/sitagliptin tablet; extended release
  • vorinostat
  • mometasone furoate

Eligibility Requirements   

Insurance Status Determined case by case
Those with Part D Eligible? Yes
Income At or below 400% of FPL
Diagnosis/Medical Criteria Not specified
US Residency Required? Yes


Obtaining Call or download
Receiving Sent to doctor or patient
Returning Mail original application. Do not fax
Doctor's Action Complete section and sign
Applicant's Action Complete section and sign
Decision Communicated Call for decision
Decision Timeframe Up to 10 business days


Amount/Supply 90 day supply with up to 3 refills, for a total of up to 1 year of medications
Sent To Doctor's office or patient's home
Delivery Time Not specified
Refill Process Patient requests refills via a toll-free number
Limit Not specified
Re-application New application yearly

Additional Information

At Merck we realize that sometimes exceptions need to be made based on the patient's individual circumstances. Individuals who do not meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial hardship, and their income meets the program criteria.

*The Enrollment Form must be mailed. Please do not fax.

Updated February 22, 2018